Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.1939
+0.0079 (4.25%)
At close: Jun 6, 2025, 4:00 PM
0.1903
-0.0036 (-1.86%)
After-hours: Jun 6, 2025, 7:39 PM EDT
Carisma Therapeutics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Carisma Therapeutics stock ranges from a low of $0.70 to a high of $1.00. The average analyst price target of $0.90 forecasts a 364.16% increase in the stock price over the next year.
Price Target: $0.90 (+364.16%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 1, 2025.
Analyst Ratings
The average analyst rating for Carisma Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 → $1 | Strong Buy | Maintains | $12 → $1 | +415.73% | Apr 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +6,088.76% | Jan 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +6,088.76% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 16, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +6,088.76% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
17.85M
from 19.63M
Decreased by -9.08%
Revenue Next Year
n/a
from 17.85M
EPS This Year
-0.62
from -1.46
EPS Next Year
-0.61
from -0.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0M | n/a | n/a | ||
| Avg | 17.9M | n/a | n/a | ||
| Low | 14.7M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.0% | - | - | ||
| Avg | -9.1% | - | - | ||
| Low | -25.1% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.36 | -0.63 | -0.53 | ||
| Avg | -0.62 | -0.61 | -0.51 | ||
| Low | -0.86 | -0.59 | -0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.